Accurate non‐invasive diagnosis and staging of non‐alcoholic fatty liver disease using the urinary steroid metabolome

BACKGROUND: The development of accurate, non‐invasive markers to diagnose and stage non‐alcoholic fatty liver disease (NAFLD) is critical to reduce the need for an invasive liver biopsy and to identify patients who are at the highest risk of hepatic and cardio‐metabolic complications. Disruption of...

Descripción completa

Detalles Bibliográficos
Autores principales: Moolla, Ahmad, de Boer, Jasper, Pavlov, David, Amin, Amin, Taylor, Angela, Gilligan, Lorna, Hughes, Beverly, Ryan, John, Barnes, Eleanor, Hassan‐Smith, Zaki, Grove, Jane, Aithal, Guruprasad P., Verrijken, An, Francque, Sven, Van Gaal, Luc, Armstrong, Matthew J., Newsome, Phillip N., Cobbold, Jeremy F., Arlt, Wiebke, Biehl, Michael, Tomlinson, Jeremy W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Urinary Steroid Metabolomics in Diagnosis and Staging of Non‐alcoholic Fatty Liver Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150165/
https://www.ncbi.nlm.nih.gov/pubmed/32298002
http://dx.doi.org/10.1111/apt.15710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150165/
https://www.ncbi.nlm.nih.gov/pubmed/32298002
http://dx.doi.org/10.1111/apt.15710

Ejemplares similares